These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 9770354)

  • 21. Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH-SY5Y human neuroblastoma cells through an alpha-, beta-, and zeta-protein kinase C-independent pathway.
    Jalava A; Akerman K; Heikkilä J
    J Cell Physiol; 1993 May; 155(2):301-12. PubMed ID: 8482723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence of a functional role for the cyclin-dependent kinase-inhibitor p21WAF1/CIP1/MDA6 in promoting differentiation and preventing mitochondrial dysfunction and apoptosis induced by sodium butyrate in human myelomonocytic leukemia cells (U937).
    Rosato RR; Wang Z; Gopalkrishnan RV; Fisher PB; Grant S
    Int J Oncol; 2001 Jul; 19(1):181-91. PubMed ID: 11408941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation.
    Asada M; Yamada T; Ichijo H; Delia D; Miyazono K; Fukumuro K; Mizutani S
    EMBO J; 1999 Mar; 18(5):1223-34. PubMed ID: 10064589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Up-regulation of p21(WAF1/CIP1) levels leads to growth suppression of prostate cancer cell lines.
    Sugibayashi R; Kiguchi Y; Shimizu T; Suzuki T; Hamada H; Takeda K
    Anticancer Res; 2002; 22(2A):713-9. PubMed ID: 12014641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defects in p21WAF1/CIP1, Rb, and c-myc signaling in phorbol ester-resistant cancer cells.
    Blagosklonny MV; Prabhu NS; El-Deiry WS
    Cancer Res; 1997 Jan; 57(2):320-5. PubMed ID: 9000576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of PMA-induced human T cell proliferation by bryostatin is associated with enhanced degradation of conventional protein kinase C (cPKC): Ca2+ signals restore mitogenic activity without abrogating enhanced cPKC degradation.
    Galron D; Tamir A; Altman A; Isakov N
    Cell Immunol; 1994 Oct; 158(1):195-207. PubMed ID: 8087865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type I interferon induction of the Cdk-inhibitor p21WAF1 is accompanied by ordered G1 arrest, differentiation and apoptosis of the Daudi B-cell line.
    Subramaniam PS; Cruz PE; Hobeika AC; Johnson HM
    Oncogene; 1998 Apr; 16(14):1885-90. PubMed ID: 9583686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic action of calcium ionophore A23187 and protein kinase C activator bryostatin 1 on human B cell activation and proliferation.
    Drexler HG; Gignac SM; Pettit GR; Hoffbrand AV
    Eur J Immunol; 1990 Jan; 20(1):119-27. PubMed ID: 1689659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of nitric oxide-evoked apoptosis by the p53-downstream target p21(WAF1/CIP1).
    Yang F; von Knethen A; Brüne B
    J Leukoc Biol; 2000 Dec; 68(6):916-22. PubMed ID: 11129661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inactive caspase 3 activates Akt in human leukemia cells susceptible or resistant to apoptosis induced by phorbol ester.
    Hah JO; Lee KA; Choi YJ; Kim WD; Park JW; Kwon TK
    Int J Oncol; 2003 May; 22(5):1111-6. PubMed ID: 12684678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of antisense p21 (WAF1/CIP1/MDA6) expression on the induction of differentiation and drug-mediated apoptosis in human myeloid leukemia cells (HL-60).
    Freemerman AJ; Vrana JA; Tombes RM; Jiang H; Chellappan SP; Fisher PB; Grant S
    Leukemia; 1997 Apr; 11(4):504-13. PubMed ID: 9096690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein kinase Cepsilon mediates PMA-induced growth inhibition of low population density NIH 3T3 fibroblasts.
    Petrovics G; Bird T; Lehel C; Oravecz T; Anderson WB
    Arch Biochem Biophys; 2002 Jan; 397(2):217-23. PubMed ID: 11795874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [G1 block of the cell cycle during differentiation of F9 cells correlates with accumulation of inhibitors of the activity of cyclin-kinase complexes of proteins p21/Waf1 and p27/Kip].
    Malashicheva AB; Kisliakova TV; Pospelov VA
    Tsitologiia; 2002; 44(7):649-55. PubMed ID: 12455373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis.
    Park WH; Seol JG; Kim ES; Hyun JM; Jung CW; Lee CC; Kim BK; Lee YY
    Cancer Res; 2000 Jun; 60(11):3065-71. PubMed ID: 10850458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potentiation of ara-C-induced apoptosis by the protein kinase C activator bryostatin 1 in human leukemia cells (HL-60) involves a process dependent upon c-Myc.
    Chelliah J; Freemerman AJ; Wu-Pong S; Jarvis WD; Grant S
    Biochem Pharmacol; 1997 Sep; 54(5):563-73. PubMed ID: 9337072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein kinase C delta inhibits Caco-2 cell proliferation by selective changes in cell cycle and cell death regulators.
    Cerda SR; Mustafi R; Little H; Cohen G; Khare S; Moore C; Majumder P; Bissonnette M
    Oncogene; 2006 May; 25(22):3123-38. PubMed ID: 16434969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation.
    Szallasi Z; Denning MF; Smith CB; Dlugosz AA; Yuspa SH; Pettit GR; Blumberg PM
    Mol Pharmacol; 1994 Nov; 46(5):840-50. PubMed ID: 7969070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of bryostatins 1 and 2 on morphological and functional differentiation of SH-SY5Y human neuroblastoma cells.
    Jalava AM; Heikkilä J; Akerlind G; Pettit GR; Akerman KE
    Cancer Res; 1990 Jun; 50(11):3422-8. PubMed ID: 2334938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Posttranslational regulation of Lck and a p36-38 protein by activators of protein kinase C: differential effects of the tumor promoter, PMA, and the non-tumor-promoter, bryostatin.
    Galron D; Ansotegui IJ; Isakov N
    Cell Immunol; 1997 Jun; 178(2):141-51. PubMed ID: 9225005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of p21WAF1/CIP1 expression by p53-independent pathways.
    Zeng YX; el-Deiry WS
    Oncogene; 1996 Apr; 12(7):1557-64. PubMed ID: 8622872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.